Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-10 4:51 pm Purchase | 2024-09-03 | 13D | Nuvation Bio Inc. NUVB | Decheng Capital China Life Sciences USD Fund III L.P. | 26,600,496 8.000% | 26,600,496 (New Position) | Filing History |
| 2024-05-21 4:49 pm Sale | 2024-05-18 | 13D | Alpine Immune Sciences, Inc. ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 0 0.000% | -8,368,166 (Position Closed) | Filing History |
| 2024-04-30 4:20 pm Purchase | 2024-04-10 | 13D | Alpine Immune Sciences, Inc. ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 8,368,166 12.800% | 7,292 (+0.09%) | Filing History |
| 2023-11-14 4:16 pm Purchase | 2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 8,360,874 14.100% | 386,667 (+4.85%) | Filing History |
| 2022-09-27 4:00 pm Purchase | 2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 7,974,207 17.600% | 2,010,246 (+33.71%) | Filing History |
| 2021-09-21 5:04 pm Purchase | 2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 5,963,961 19.600% | 1,554,240 (+35.25%) | Filing History |